Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Bisphosphonates

Bisphosphonates Newsletter

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit 05 Feb 2026 01:56 GMT
… compared to the placebo or bisphosphonate control groups, respectively. Such statements … (“AFR”) compared to placebo or bisphosphonates, respectively, despite improved bone mineral …
INVESTOR ALERT: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead the Ultragenyx Class Action Lawsuit – RGRD Law 05 Feb 2026 00:44 GMT
… rate compared to placebo or bisphosphonates, respectively.” Ultragenyx allegedly attributed the …
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Ultragenyx Pharmaceutical Inc. Common Stock and Sets a Lead Plaintiff Deadline of April 6, 2026 04 Feb 2026 23:42 GMT
… rate compared to placebo or bisphosphonates, respectively.” The Company attributed the …
Vibration Therapy Boosts Success of Dental Implants 04 Feb 2026 15:00 GMT
… osteoporosis medications such as the bisphosphonate Fosamax that stimulate bone growth …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Mereo BioPharma Group plc – MREO 03 Feb 2026 19:06 GMT
… rate compared to placebo or bisphosphonates, respectively. Both studies achieved their … density against comparators (placebo and bisphosphonates) with strong statistical significance. There …
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE 03 Feb 2026 19:08 GMT
… rate compared to placebo or bisphosphonates, respectively. Both studies achieved their … density against comparators (placebo and bisphosphonates) with strong statistical significance. There …
Real-World Comparability of Antiresorptive Osteoporosis Treatment Groups Among Treatment-Naïve and Treatment-Experienced Women Ages 55 and Older in the United States 02 Feb 2026 13:58 GMT
… include antiresorptives such as oral bisphosphonates (BPs) (alendronate, risedronate, and … -naïve cohort. Similarly, oral bisphosphonates represent a heterogeneous group of … or fractures occurring despite oral bisphosphonate treatment. Prescribers may also …
Black Phosphorus Nanomaterials and the Senescent Osteoimmune Microenvironment: Mechanisms, Opportunities, Challenges, and Future Outlook 02 Feb 2026 13:58 GMT
… available anti-osteoporotic agents, including bisphosphonates, denosumab, and teriparatide, predominantly act …
Denosumab Use Linked to Lower Knee OA Risk in Osteoporosis 02 Feb 2026 08:18 GMT
… with osteoporosis, denosumab use vs bisphosphonate use was associated with a … osteoporosis treated with denosumab vs bisphosphonates. They identified 360,283 adults … groups. TAKEAWAY: Denosumab use vs bisphosphonate use was associated with reduced …
I was able to reverse my osteoporosis thanks to this simple treatment. It's given me my life back... but this is the profoundly unfair reason it isn't being offered to other sufferers: RUTH SUNDERLAND 01 Feb 2026 14:12 GMT
… infusions of zoledronic acid – a bisphosphonate – every 18 months to lock …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS